Tasman Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?
TASMAN PHARMA has two approved drugs.
There is one US patent protecting TASMAN PHARMA drugs.
There are six patent family members on TASMAN PHARMA drugs in six countries.
Summary for Tasman Pharma
| International Patents: | 6 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Tasman Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Tasman Pharma | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 215186-001 | Feb 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tasman Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005007168 | ⤷ Sign Up |
| Canada | 2532648 | ⤷ Sign Up |
| Spain | 2436213 | ⤷ Sign Up |
| European Patent Office | 1646393 | ⤷ Sign Up |
| New Zealand | 527142 | ⤷ Sign Up |
| Australia | 2004257556 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
